Clinical Trial Update: Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021) [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing safety, tolerability, and immunogenicity of Rotateq vaccination in healthy infants in India has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis
• Rotavirus Infections

Drugs mentioned

• RotaTeq (rotavirus vaccine, pentavalent)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Gastroenteritis, Rotavirus | Phase 3 | Status: COMPLETED | Results posted: 2010-03-11